Article

Low antioxidant levels and exposure to sunlight likely to damage vision

The combination of low antioxidant levels and exposure to sunlight may damage vision and also is linked to age-related macular degeneration, according to a study published in the October issue of the Archives of Ophthalmology.

London-The combination of low antioxidant levels and exposure to sunlight may damage vision and also is linked to age-related macular degeneration (AMD), according to a study published in the October issue of the Archives of Ophthalmology.

Studies suggest that blue light or short-wavelength light may damage the retina and contribute to the development of AMD. Antioxidant enzymes including vitamins C and E, the carotenoids, lutein, zeaxanthin, and zinc may protect against the harmful effects of blue light on the retina, according to a prepared statement from the American Medical Association.

“The retina is vulnerable to the damaging effects of light,” wrote study authors. “While wavelengths in the UV radiation range are largely absorbed by the cornea and lens, the retina is exposed to visible light, including blue light.”

Of the 4,400 participants of the European Eye Study, 2,117 did not have AMD, 101 had neovascular AMD, and 2,182 had early stage AMD. Although there was no association between blue-light exposure and early AMD, blue-light exposure was associated with neovascular AMD in one-fourth of individuals with the lowest antioxidant levels.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.